Georg-Speyer-Haus. Foto: Andreas Reeg, Tel: +40-171-5449247, andreas.reeg@t-online.de, www.andreasreeg.de
Research
Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com

Ferroptosis Enables Immune Therapies to Fight Against Liver tumors and Liver Metastases

| Frankfurt am Main, January 29, 2023 – Researchers from the Georg-Speyer-Haus in Frankfurt am Main and the University Hospital and Goethe University Frankfurt, identified a new combination therapy to boost anti-tumor immune therapy in liver cancer and liver metastasis. Over the last decade, immune therapies have become part of the portfolio for the fight… [mehr]

Tumor-associated macrophages in brain metastases

Tumor-associated macrophages as therapeutic targets in brain metastases Frankfurt am Main, 10/19/2021 – The Max-Eder Junior Group led by Dr. Lisa Sevenich (Georg-Speyer-Haus) demonstrated in collaboration with researchers and clinicians at the University of Lausanne and the Institute of Neurology (Edinger Institute, University Hospital Frankfurt), that TAM-targeted therapies by colony stimulating factor 1 receptor (CSF1R)… [mehr]

Dr. Mélanie Tichet

Our research focuses on unraveling the complexity of the interplay between cancer and stromal cells in the tumor microenvironment (TME), as tumors erect multiple barriers to evade immune destruction, resulting in non-responsiveness to treatments. Therefore, we are delving into the roles and regulation of suppressive cell populations to identify vulnerabilities in cancer and stromal cell crosstalk that can be targeted therapeutically….

Gautami Gaidhani

Gautami completed BSc (Blended) in Bioscience, a special degree granted by Savitribai Phule Pune University (India) and designed by University of Melbourne (Australia). Later during the training at IISER Pune (India), she studied the role of Api5 protein in breast carcinogenesis and explored her joint interest in molecular and cancer biology. In 2023, she was… [mehr]

Leoni Moldaner

Leoni received her Bachelor’s degree in Biology from the Technical University of Darmstadt, where she investigated immunogenicity of cell death at the GSI Helmholtz Center for Heavy Ion Research for her thesis. In her Master thesis in the group of Dr. Tatarova, she explored histopathology staining methods and bioinformatic tools to study resistance mechanisms in… [mehr]

Florian Greten is listed as Highly Cited Researcher 2023

| Frankfurt am Main, November 15, 2023| Florian Greten, Director of the Georg-Speyer-Haus and speaker of the LOEWE Centre Frankfurt Cancer Institute is 2023 amongst the prestigious Highly Cited Researchers selected by Claviate (Web of Science). His work on colorectal cancers and especially the tumor microenvironment in the last decade had a major impact on… [mehr]

Dr. Zuzana Tatarova

DKTK Research Group for Therapy Resistance Systems Biology of Breast Cancer in Therapy Resistance   Recent integration of tumor devices and high-dimensional computational data from mouse mammary carcinoma studies re-enforced the concept that cancer neighborhood (local tumor microenvironment, TME) can determine efficacy of anti-cancer therapies. We hypothesize that achieving durable cancer control will require systematic… [mehr]

Henner Farin is accepted into the Heisenberg Program of the German Research Foundation (DFG)

| Frankfurt am Main, November 10, 2023| The title of the approved research project is: "3D tumor-stroma models for the investigation of the phenotypic map in colorectal carcinoma". The project investigates how colorectal cancer cancers and their surrounding cells interact in the tumor microenvironment and where differences exist between individual tumors. In a cell culture… [mehr]

Anna Wolfram

Anna Wolfram completed her Bachelor’s and Master’s degree in Biochemistry at the University of Heidelberg. Anne specialized on the multidisciplinary process of drug design in both her bachelor’s and master’s thesis. For the former, she worked on hypoxia activated prodrugs in the Translational Therapeutics Team (ACSRC, New Zealand). For the later, Anna worked on the… [mehr]

Pomegranate fueling cancer therapy

Researchers identify way to boost tumor-fighting immune cells | Frankfurt am Main, October 18, 2022 – Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, were able to identify a new approach for the therapy of colorectal cancer (CRC) as part of an interdisciplinary project of the LOEWE Center Frankfurt Cancer Institute (FCI). In preclinical… [mehr]